Optima Health PLC (AIM:OPT) says revenue hit £105 million in the year to 31 March, with second-half growth up 7%. It’s completed three acquisitions and landed a major contract supporting the UK armed forces.
Iofina PLC (AIM:IOF, OTC:IOFNF) posted record revenue of $54 million and sees stable iodine prices holding through 2025. It’s on track to open its eighth plant this summer, with a ninth in the pipeline.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) raised £500k to fund a gene therapy trial in ageing dogs. The company says it’s a big step in proving its SIRT6 technology beyond mice.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
